Rheumatoid arthritis (RA) is an autoimmune condition that, when well-controlled, is generally insurable at standard or near-standard rates at most major carriers. RA with significant joint damage, high disease activity, or systemic complications (particularly cardiovascular or pulmonary involvement) results in higher table ratings. Medication type, disease activity scores, joint damage level, and the presence of extra-articular complications are the variables that drive underwriting outcomes.
What Underwriters Evaluate for Rheumatoid Arthritis
RA Profile: General Underwriting Outlook
| RA Profile | Typical Rating | Best Achievable | Notes |
|---|---|---|---|
| Remission or low activity, methotrexate or hydroxychloroquine | Standard to Table 2 | Standard at many carriers | Well-controlled RA is widely insurable at favorable rates |
| Low-moderate activity, biologic therapy, minimal damage | Table 2–4 | Table 2 at competitive carriers | Biologics add rating but remain insurable with good response |
| Moderate-high activity, significant joint damage | Table 4–8 | Table 4 | Limited options; carrier selection important |
| RA with ILD, cardiovascular involvement, or major disability | Table 8–10 or decline | Very limited options | Extra-articular complications severely restrict the field |
Guidelines current as of 2025–2026. Verify with us before applying.
Have Rheumatoid Arthritis? Let’s Find Your Best Rate.
Well-controlled RA is insurable at favorable rates at many carriers. We match your disease profile to the right carrier before any application is submitted.
Browse All High-Risk Conditions
Atrial Fibrillation | Heart Attack / Heart Disease | High Blood Pressure | Stroke / TIA | Diabetes | Obesity | Thyroid Disease | COPD / Emphysema | Sleep Apnea | Lupus | Multiple Sclerosis | Kidney Disease (CKD) | Hepatitis B & C | Crohn’s Disease | Ulcerative Colitis | Cancer History | Anxiety / Depression | Bipolar Disorder | Epilepsy | PTSD | HIV / AIDS | DUI / DWI | Drug Use / Abuse | Marijuana Use | Aviation / Pilots
Understanding Your Rating: Life Insurance Risk Classifications | Table Ratings Explained (B–J) | Flat Extra Ratings
Authoritative Resources: Life insurance underwriting practices are regulated by the NAIC. Insurers may check your health history through the MIB Group — you can request your free annual MIB report at mib.com.
Frequently Asked Questions
Can I get life insurance with rheumatoid arthritis?
Yes. Rheumatoid arthritis is broadly insurable when well-controlled. RA in remission or low disease activity with minimal joint damage can qualify for standard or near-standard rates at many major carriers. Higher disease activity, significant joint damage, or RA-related systemic complications such as interstitial lung disease or cardiovascular involvement result in higher table ratings.
Do biologic medications for RA hurt my life insurance application?
Biologics such as TNF inhibitors or JAK inhibitors are a signal of more severe RA requiring more aggressive treatment, which underwriters note. However, a good treatment response on biologics — demonstrated by low disease activity and minimal joint damage — can still result in Preferred or standard rates at many carriers. The response to treatment matters more than the specific medication used.
What RA factors most affect underwriting outcomes?
The most important factors are current disease activity (DAS28 score), degree of joint damage and functional disability, medication regimen, and the presence of extra-articular complications. RA limited to the joints with low disease activity and no cardiovascular or pulmonary involvement is the most favorable presentation. Significant erosive disease, functional impairment, or RA-related lung disease substantially restricts options.
Does seropositivity (positive RF or anti-CCP) affect my life insurance rates?
Seropositive RA — positive rheumatoid factor or anti-CCP antibodies — is generally associated with more aggressive disease and may be viewed slightly less favorably than seronegative RA at the same disease activity level. However, current disease activity, functional status, and the absence of extra-articular complications are more influential factors than seropositivity alone.
Can I get Preferred rates with rheumatoid arthritis?
Preferred rates are achievable for RA applicants in documented remission or low disease activity, on methotrexate or hydroxychloroquine monotherapy, with minimal joint damage and no extra-articular complications. Applicants on biologic therapy with good response may also achieve Preferred at competitive carriers. The key factors are documented low disease activity scores and a clean overall health profile.